Becton Dickinson & Co. (NYSE:BDX) shares lost about 1% today after the medical products maker reported lackluster 2nd-quarter results, despite beating Wall Street’s earnings expectations by a penny.
MassDevice Earnings Roundup
Teleflex gains on acquisitions, Q1 numbers | Wall Street Beat
Shares of Teleflex (NYSE:TFX) are up today after the medical device maker revealed a pair of acquisitions and earnings well above Wall Street’s expectations.
Limerick, Pa.-based Teleflex said it inked deals to buy the EZ-Blocker pulmonary catheter technology and Axiom Technology Partners, which makes the EFx line of laparoscopic fascial closure devices.
Lawyers probe Cynosure execs’ pay as Q1 sales, profits soar
Haemonetics gains on Q4, merger news
Hologic falls on swing to Q2 red, Gen-Probe deal
Covidien beats The Street, maintains guidance
Covidien (NYSE:COV) posted healthy growth during its fiscal 2nd quarter, beating Wall Street’s estimates and maintaining its guidance for the rest of the year.
The Mansfield, Mass.-based med-tech titan posted sales of $2.95 billion in the 3 months ended March 30, a 5% uptick from the same period last year.
Zimmer slides on Q1 results | Earnings Roundup
Zimmer slides on Q1 results
Investors sent shares of Zimmer (NYSE:ZMH) down 5% this morning in pre-market trading after the orthopedic device maker reported sales and earnings in-line with Wall Street’s expectations, but lackluster sales of hip and knee implants.
The Warsaw, Ind.-based company posted profits of $209.6 million, or $1.17 per diluted share, on sales of $1.14 billion for the 3 months ended March 31.
MassDevice.com +3 | The top 3 med-tech stories for April 25, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Bard beats The Street with Q1 earnings
Investors on Wall Street shrugged at C.R. Bard‘s (NYSE:BCR) 1st-quarter results despite Street-beating earnings, sending shares down a tick today after instigating a slight overnight uptick.
The medical device giant reported profits of $138.7 million, or $1.60 per diluted share, on sales of $730 million for the 3 months ended March 31, for a bottom-line gain of 5.2% and top-line growth of 4.2%.
Align Technology gains despite missing Q1 earnings expectations
Shares of Align Technology (NSDQ:ALGN)
rose nearly 16% on Wall Street yesterday after the company reported 1st-quarter sales and earnings growth rates that each hovered around 30%.